Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma

21 Aug 2014

Abstract excerpt

PURPOSE: To examine the clinical utility of intratumor microRNAs (miRNA) as a biomarker for predicting responses to platinum-based doublet chemotherapy in patients with recurring lung adenocarcinoma (LADC). EXPERIMENTAL DESIGN: The expression of miRNAs was examined in LADC tissues surgically resected from patients treated with platinum-based doublet chemotherapy at the time of LADC recurrence. Microarray-based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to Lung Cancer Treatments and Mutations
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25142144
DOI: 10.1158/1078-0432.ccr-14-1096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung AdenocarcinomaPMID 25142144Read ↗

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to CisplatinSemantic proximity Read ↗

microRNA expression pattern as an ancillary prognostic signature for radiotherapySemantic proximity Read ↗

Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.Semantic proximity Read ↗

A validated miRNA profile predicts response to therapy in esophageal adenocarcinomaSemantic proximity Read ↗

An intronic polymorphism in GRP78 improves chemotherapeutic prediction in non-small cell lung cancer.Semantic proximity Read ↗

Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer.Semantic proximity Read ↗

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.Semantic proximity Read ↗

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy.Semantic proximity Read ↗

High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancerSemantic proximity Read ↗

Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients.Semantic proximity Read ↗

Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer.Semantic proximity Read ↗

Identification of miR-210 and combination biomarkers as useful agents in early screening non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.